ZO Skin Health has expanded its skincare range with three new targeted formulations containing 0.3% retinol: Wrinkle + Texture, Retinol Skin Brightener and Clear Renewal. Each product uses the brand's ZO-RDS™ Retinol Delivery System, a liposome-based technology designed to support ingredient stability, controlled release and delivery within the epidermis. The launch addresses three distinct skincare priorities: visible signs of ageing, uneven skin tone and discolouration, and blemish-prone skin with excess surface oil and post-blemish marks.
A targeted approach to retinol formulation
Retinol continues to play a role in topical skincare formulations aimed at improving the appearance of fine lines, uneven texture, discolouration and blemish-related concerns.
ZO Skin Health's latest launch introduces three products with the same stated retinol concentration but different intended applications. Each contains 0.3% retinol and uses the brand's ZO-RDS™ Retinol Delivery System.
The new products are:
The supplied product information lists an RRP of £150 for each 50 ml formulation.
ZO-RDS™: the delivery technology behind the launch
A central feature of the three formulations is ZO-RDS™, the brand's Retinol Delivery System.
The technology uses liposome-based encapsulation, with the stated aim of supporting retinol stability and controlled delivery.
The manufacturer identifies several aspects of the system.
Retinol stability
The encapsulation structure is designed to help protect retinol from oxidation and degradation, including exposure to light. Ingredient stability is an important consideration in retinol formulation because the performance of a product depends not only on its stated concentration but also on how well the ingredient is maintained within the formulation.
Controlled release and tolerability
The liposomal structure is intended to support gradual release of retinol. The manufacturer positions this approach as a way of supporting efficacy while minimising irritation and improving tolerability.
For practitioners, tolerability remains a key consideration when recommending retinol products. Individual responses can vary, and the use of a delivery system does not remove the need to discuss application instructions and possible irritation.
Dual-depth delivery
ZO Skin Health describes a dual-depth delivery approach, with different pathways intended to target the viable epidermis and more superficial epidermal layers.
The manufacturer's stated rationale is to support delivery for different concerns, including wrinkles and pigmentation. The three products apply this delivery technology to distinct skincare objectives.
Product focus 1: Wrinkle + Texture 0.3
Wrinkle + Texture is designed for patients concerned about the visible signs of ageing, particularly fine lines, wrinkles and uneven skin texture.
The manufacturer describes the formulation as intended to:
-
Smooth rough skin texture.
-
Soften the appearance of fine lines and wrinkles.
-
Support the appearance of firmness, elasticity and resilience.
-
Hydrate and plump the skin's appearance.
Reported clinical findings
The launch material includes results from a 12-week independent, third-party clinical study involving 34 women aged 40–65 with Fitzpatrick skin types II–IV. Participants had moderate wrinkles, fine lines and discolouration, among other parameters.
The supplied protocol states that Wrinkle + Texture 0.3 was applied once daily during the first week and twice daily thereafter.
The manufacturer reports the following results:
| Assessment point | Reported finding |
|---|---|
| Week 4 | 100% of subjects showed improvement in overall appearance |
| Week 8 | 100% showed improvement in skin texture |
| Week 12 | 43% improvement in the appearance of skin texture |
| Week 12 | 22% improvement in visible global facial wrinkles |
The material also reports zero irritation among subjects at week four.
These figures relate specifically to Wrinkle + Texture 0.3 and the stated study protocol. The supplied material does not provide equivalent study findings for Retinol Skin Brightener or Clear Renewal.
Product focus 2: Retinol Skin Brightener 0.3
Retinol Skin Brightener is designed to address the appearance of uneven skin tone and discolouration.
The manufacturer describes the formulation as intended to:
-
Visibly brighten the skin.
-
Improve the appearance of uneven tone.
-
Reduce the visible appearance of discolouration.
-
Promote smoother-looking skin.
For aesthetic professionals, the distinction between different causes of pigmentation remains important when discussing topical skincare. Sun-related discolouration, post-inflammatory hyperpigmentation and other pigmentary concerns may require different management approaches.
The product's intended focus can inform skincare discussions, while assessment of the patient's presentation and realistic expectations remains essential.
Product focus 3: Clear Renewal 0.3
Clear Renewal is positioned for blemish-prone skin, with a focus on excess surface oil, visible congestion, texture and post-blemish marks.
According to the manufacturer, its intended benefits include:
-
Supporting natural cellular turnover.
-
Improving the appearance of congestion.
-
Refining the look of skin texture.
-
Reducing the visible appearance of post-blemish marks.
-
Reducing excess surface oil.
-
Supporting a more balanced-looking complexion.
The manufacturer also describes the formulation as intended to support the skin barrier while minimising dryness or peeling.
In practice, professionals should distinguish between active acne and residual post-inflammatory marks. Patients with persistent inflammatory acne, pain or scarring may need assessment and management beyond cosmetic skincare.
Integrating the formulations into a skincare protocol
The launch material places the products within the ZO Skin Health protocol framework, which comprises three broad stages.
Step 1: Getting Skin Ready®
The manufacturer's protocol begins with preparing the skin, selecting cleanser, exfoliator and toner according to skin type.
Step 2: Prevent + Correct
This is the stage in which the targeted retinol products are positioned.
The supplied protocol identifies:
-
Ageing: Wrinkle + Texture 0.3.
-
Brightening: Retinol Skin Brightener 0.3.
-
Acne: Clear Renewal 0.3.
The protocol also lists other supporting products for the different pathways, including Daily Power Defense, Brightalive Skin Brightener, Complexion Clarifying Serum and Exfoliation Accelerator.
Product selection and layering should follow current manufacturer guidance and take account of the patient's existing routine, skin condition and tolerance.
Step 3: Protect
The final stage emphasises sunscreen selection based on the patient's preferences and lifestyle, with the aim of supporting consistent use.
Sun protection is particularly relevant when managing visible signs of photoageing and uneven pigmentation.
Considerations for patient consultations
The three formulations give practitioners distinct product options within a shared 0.3% retinol range. During consultations, several factors remain relevant when considering suitability.
Primary concern: Identify whether the main objective is improving the appearance of fine lines and texture, addressing uneven tone or supporting a routine for blemish-prone skin.
Existing skincare: Review current active ingredients, prescription treatments and recent procedures before recommending changes.
Skin sensitivity: Discuss the possibility of dryness, redness, peeling and stinging, particularly when introducing retinol.
Application guidance: Follow the current product instructions rather than assuming that the study protocol applies to every patient.
Sun protection: Reinforce the importance of appropriate daily sunscreen as part of a skincare plan.
Expectations: Explain that individual results vary and that the clinical results reported for Wrinkle + Texture 0.3 should not be assumed to apply identically to the other two products.
Frequently asked questions
Which new products has ZO Skin Health launched?
The launch comprises Wrinkle + Texture 0.3, Retinol Skin Brightener 0.3 and Clear Renewal 0.3. All three are formulated with 0.3% retinol and use the ZO-RDS™ Retinol Delivery System.
What is the purpose of ZO-RDS™?
ZO-RDS™ is the brand's liposome-based retinol delivery technology. It is designed to support retinol stability, controlled release and delivery within the epidermis, with the aim of improving performance and tolerability.
What clinical results have been reported?
For Wrinkle + Texture 0.3, the manufacturer reports a 12-week study involving 34 women, with improvements in overall appearance at week four, skin texture at week eight, and the appearance of skin texture and global facial wrinkles at week 12.
Do all three products have the same clinical study results?
The supplied launch material provides detailed study results for Wrinkle + Texture 0.3 only. It does not include equivalent clinical results for Retinol Skin Brightener 0.3 or Clear Renewal 0.3.
How are the three products positioned within the ZO protocol?
Wrinkle + Texture 0.3 is listed under the ageing pathway, Retinol Skin Brightener 0.3 under brightening, and Clear Renewal 0.3 under acne. These sit within the Prevent + Correct stage of the manufacturer's wider protocol.
What should practitioners discuss when recommending retinol?
Relevant considerations include the patient's primary skin concern, existing routine, sensitivity, application instructions, sun protection and realistic expectations. Retinol can cause irritation, and individual tolerance varies.
What is the recommended retail price?
The supplied product material lists an RRP of £150 for each 50 ml product.
Three formulations, one delivery system
The launch of Wrinkle + Texture 0.3, Retinol Skin Brightener 0.3 and Clear Renewal 0.3 gives ZO Skin Health three targeted options built around its ZO-RDS™ Retinol Delivery System.
The formulations address different skincare priorities, from visible wrinkles and uneven texture to discolouration, congestion and post-blemish marks. The manufacturer-reported clinical findings for Wrinkle + Texture 0.3 provide further detail on the outcomes observed in its 12-week study.
For aesthetic professionals, understanding the intended focus of each formulation, the delivery technology and the available product-specific evidence can support informed skincare discussions and appropriate integration into patient routines.
